BETHPAGE, N.Y., Nov. 17, 2016 /PRNewswire-USNewswire/ -- A nationwide omnibus survey revealed that 50 percent of Americans questioned believe there is a universal screening test for pancreatic cancer* when in fact there is no widely used test method. More than 53,000 Americans will be diagnosed with pancreatic cancer this year and nearly 42,000 won't survive. Early detection is necessary for increasing survival rates.
"In honor of World Pancreatic Cancer Day today, we want to remind people that developing an effective early detection test is critical, especially for those who are at a higher risk for developing pancreatic cancer," says Kerri Kaplan, President and CEO of the Lustgarten Foundation. As the rates of incidence and death from other cancers are declining, pancreatic cancer is on the rise. In 2016, pancreatic cancer is expected to surpass breast cancer to become the third deadliest cancer in the United States, underscoring the need for an emphasis on research into early detection. Hofstra University marketing professor Joel Evans was one of the lucky ones. Because he is a diabetic, he gets his blood checked frequently. Two years ago, a routine blood test showed an early cancer marker. As a result, he was screened and had surgery before his pancreatic cancer had progressed. His long-term prognosis is strong. "We want every story to be like Joel's," Kaplan said. "And with the work we are currently funding to develop reliable early detection methods, our vision is becoming closer to a reality."